A Study to Evaluate Efficacy and Safety of Daprodustat Compared to Darbepoetin Alfa in Japanese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD)
Clinical trial NCT02969655 · COMPLETED
Trial details
- NCT number
- NCT02969655
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-21
- Primary completion
- 2018-07-02
- Enrollment
- 271
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.